Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia

BACKGROUND: Antipsychotic treatment-induced hyperprolactinemia is a highly distressing and disabling side effect for patients. The use of add-on aripiprazole has been identified as a possible treatment strategy in this situation. However, data on prolactin changes with add-on aripiprazole in a real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Raveendranthan, Dhanya, Rao, Naren P., Rao, Mukund G., Mangot, Ajish G., Varambally, Shivaram, Kesavan, Muralidharan, Venkatasubramanian, Ganesan, Gangadhar, Bangalore N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795677/
https://www.ncbi.nlm.nih.gov/pubmed/29403128
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_147_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795677/
https://www.ncbi.nlm.nih.gov/pubmed/29403128
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_147_17

Ejemplares similares